Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/06/2010WO2010049900A1 Statin nanoparticles
05/06/2010WO2010049899A1 Nanoparticles of beta-lactam derivatives
05/06/2010WO2010049898A1 Injectable polydeoxyribonucleotide composition for the treatment of osteoarticular diseases
05/06/2010WO2010049841A1 7-azaspiro [3.5] nonane-7-carboxamide compounds as modulators of fatty acid amide hydrolase
05/06/2010WO2010049798A1 A method of characterizing phytochemicals from trigonella foenum graceum
05/06/2010WO2010049731A1 Pyrazolo- and imidazopyridinylpyrimidineamines as igf-1r tyrosine kinase inhibitors
05/06/2010WO2010049709A2 Therapeutic compositions
05/06/2010WO2010049707A2 Fruit extracts
05/06/2010WO2010049705A2 Therapeutic compositions
05/06/2010WO2010049678A2 Treatment of energy utilization diseases
05/06/2010WO2010049637A1 Aqueous saline solutions for the destruction of fatty tissue
05/06/2010WO2010049635A1 Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betahsd1
05/06/2010WO2010049525A1 Choline and tromethamine salt of licofelone
05/06/2010WO2010049485A2 Topical formulation of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate
05/06/2010WO2010049481A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
05/06/2010WO2010049466A1 Thienotriazolodiazepine derivatives active on apo a
05/06/2010WO2010049451A2 C-glycosidic analogues of alpha-galactosylceramids having immunostimulating and immunoregulating properties
05/06/2010WO2010049449A2 Novel salts of sunitinib
05/06/2010WO2010049438A2 Improved methods of using phosphoantigens for the treatment of diseases
05/06/2010WO2010049366A1 Tricyclic compounds as glutamate receptor modulators
05/06/2010WO2010049331A1 Heterocyclic antiviral arylpyridone derivatives
05/06/2010WO2010049302A1 Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
05/06/2010WO2010049182A2 Treatment of retroviral reservoirs exploiting oxidative stress
05/06/2010WO2010049152A1 Novel composition for the preparation of mature dendritic cells
05/06/2010WO2010049146A1 Substituted spiroamines
05/06/2010WO2010049144A2 Methods of identification of novel ligands for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (nr1f3) activity
05/06/2010WO2010049142A1 Nutrition composition containing omega-3 fatty acids and mcts
05/06/2010WO2010049073A1 1,1,1-trifluoro-3-amino-3-heteroaryl-2-propanoles, a process for their production and their use as anti-inflammatory agents
05/06/2010WO2010048955A1 Composition comprising a glycoside of a mono- or diacyiglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
05/06/2010WO2010048880A1 The nitropyridinyl ethyleneimine compound, the pharmaceutical composition containing it, the preparation method and use thereof
05/06/2010WO2010048788A1 A ophthalmic flurbiprofen ester nano-emulsion in-situ gel formulation and the preparation method thereof
05/06/2010WO2010048731A1 Aminoacyl trna-synthetase inhibitors as broad-spectrum immunosuppressive agents
05/06/2010WO2010048722A1 Compositions comprising a calcium channel blocker or a calmodulin blocker for use in the removal of hyperplastic skin lesions
05/06/2010WO2010048716A1 Composition and method for treating fibrosis
05/06/2010WO2010048712A1 Ciclopirox and cytarabine for the treatment of leukemic disorders
05/06/2010WO2010048675A1 Anti-inflammatory pharmaceutical compositions comprising a corticosteroid, hexylene glycol and water
05/06/2010WO2010033733A4 Folate receptor binding conjugates of antifolates
05/06/2010WO2010030976A3 Methods and compositions for inhibiting atherosclerosis and vascular inflammation
05/06/2010WO2010030948A3 Hedgehog signaling and cancer stem cells in hematopoietic cell malignancies
05/06/2010WO2010030538A3 Compounds for the treatment of hepatitis c
05/06/2010WO2010030396A3 Novel shrna gene therapy for treatment of ischemic heart disease
05/06/2010WO2010030167A3 Method of detection and diagnosis of oral and nasopharyngeal cancers
05/06/2010WO2010029577A3 Anti-cancer drugs and uses relating thereto for metastatic malignant melanoma and other cancers
05/06/2010WO2010029344A3 Hyaluronic acid cryogel - compositions, uses, processes for manufacturing
05/06/2010WO2010029302A3 Compounds for treating viral infections
05/06/2010WO2010029278A3 Isolation and identification of glycosaminoglycans
05/06/2010WO2010028515A3 A pentoxifilin-based dermatological pharmaceutical composition, for topical application, in cream, gel, ointment, solution, emulsion, liposome and microcapsule form
05/06/2010WO2010027848A3 Forms of lapatinib compounds and processes for the preparation thereof
05/06/2010WO2010027746A3 Hedgehog pathway modulators
05/06/2010WO2010024911A8 Methods for increasing neurogenesis
05/06/2010WO2010023658A3 Compositions and methods for the treatment of glioblastoma
05/06/2010WO2010021702A9 Self-avoiding molecular recognition systems in dna amplification
05/06/2010WO2010019574A9 A micro-rna that promotes vascular integrity and uses thereof
05/06/2010WO2010019450A3 Synergizing active compounds for treating inflammation and other conditions
05/06/2010WO2010017478A3 Pak1 agonists and methods of use
05/06/2010WO2010017368A3 Methods and compositions for treating anxiety
05/06/2010WO2010017131A3 Modulation of toll-like receptor 7 expression by antisense oligonucleotides
05/06/2010WO2010014889A3 Nitro fatty acids as regiomers and related mimetics
05/06/2010WO2010012964A3 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof
05/06/2010WO2010012381A8 Streptospirole derivatives
05/06/2010WO2010011836A3 Treating various disorders with 7,8-dihydroxyflavone and derivatives thereof
05/06/2010WO2010011811A4 3-(phenoxyphenylmethyl)pyrrolidine compounds
05/06/2010WO2010011581A3 Polysaccharides extract from dendrobium for treating allergic diseases
05/06/2010WO2010009038A3 Antisense formulation
05/06/2010WO2010008554A3 Methods and products for treating proliferative diseases
05/06/2010WO2010005961A3 Nutritive compositions and methods of using same
05/06/2010WO2010004221A3 Use of indole derivatives as nurr-1 activators for treating parkinson’s disease
05/06/2010WO2010002970A3 Isolation of cyclopamine
05/06/2010WO2010002965A3 Pneumonia treatment
05/06/2010WO2010002675A3 Quinine sulfate/bisulfate solid complex; methods of making; and methods of use thereof
05/06/2010WO2009158625A3 Compositions and methods for treating or preventing gastrointestinal disorders and gerd-related respiratory disorders
05/06/2010WO2009158031A3 Methods and compositions for therapeutic treatment
05/06/2010WO2009155527A9 Phosphatidylinositol 3 kinase inhibitors
05/06/2010WO2009154828A9 INHIBITORS OF RecA ACTIVITIES FOR CONTROL OF ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
05/06/2010WO2009154777A3 Process for preparing and drying solid rasagiline base
05/06/2010WO2009153597A3 Compositions with and process for methylmorpholin-subsituted pyrido [2, 3-d] pyrimidines
05/06/2010WO2009151997A8 Process for producing bicycloaniline derivatives
05/06/2010WO2009151910A3 Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
05/06/2010WO2009151598A8 Diazacarbazoles and methods of use
05/06/2010WO2009150408A3 Topical antimuscarinic formulations
05/06/2010WO2009145358A3 Medicament for the prophylaxis or treatment of hypertension
05/06/2010WO2009143347A3 Varenicline tosylate, an intermediate in the preparation process of varenicline l-tartrate
05/06/2010WO2009139630A9 Method for efficient exon (44) skipping in duchenne muscular dystrophy and associated means
05/06/2010WO2009138600A3 Novel uses of d-mannopyranose derivatives activating angiogenesis
05/06/2010WO2009118359A3 Capsule for the prevention of cardiovascular diseases
05/06/2010WO2009108931A3 Method of treating cancer
05/06/2010WO2009106749A3 Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
05/06/2010WO2009104198A3 Metal conjugates of indole 3-aldehyde azine and its derivatives and uses thereof
05/06/2010WO2009100367A3 Compositions comprising topical dpd inhibitors and methods of using same in the treatment of hand-foot syndrome
05/06/2010WO2009064374A3 Oral formulations of bis(thiohydrazide amides)
05/06/2010WO2009048993A3 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators
05/06/2010WO2007012626A3 Novel method for producing tiotropium salts
05/06/2010US20100113861 Metallic nanoparticles with coated shells and applications of same
05/06/2010US20100113820 asthma, allergic conditions such as rhinitis, inflammatory bowel disease such as ulcerative colitis and Crohn's disease, rheumatoid arthritis, atopic dermatitis, multiple sclerosis; condensing N-(2,6-Difluorobenzoyl)-4-(2,6-dimethoxy-4-formal methylphenyl)-L-phenylalanine ethyl ester with ethanol
05/06/2010US20100113810 Treatment of neurodegenerative conditions
05/06/2010US20100113796 Indole derivatives as s1p1 receptor
05/06/2010US20100113722 Sulfur chelated ruthenium compounds useful as olefin metathesis catalysts
05/06/2010US20100113613 cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
05/06/2010US20100113612 Novel use of hydroxytyrosol and olive extracts/concentrate containing it
05/06/2010US20100113611 Novel use of hydroxytyrosol
1 ... 2278 2279 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 ... 7860